Citadel Advisors
SRTA

Citadel Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

Citadel Advisors’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55.6K Sell
13,300
-1,100
-8% -$5.29K ﹤0.01% 12365
2025
Q4 		$69.3K Sell
14,400
-31,800
-69% -$154K ﹤0.01% 11871
2025
Q3 		$234K Sell
46,200
-17,000
-27% -$75.1K ﹤0.01% 10896
2025
Q2 		$255K Buy
63,200
+6,400
+11% +$20.8K ﹤0.01% 10166
2025
Q1 		$155K Buy
56,800
+25,500
+81% +$91.5K ﹤0.01% 10827
2024
Q4 		$133K Buy
31,300
+4,800
+18% +$18.3K ﹤0.01% 11067
2024
Q3 		$77.9K Sell
26,500
-5,900
-18% -$18.8K ﹤0.01% 11445
2024
Q2 		$113K Sell
32,400
-11,200
-26% -$37.4K ﹤0.01% 10742
2024
Q1 		$124K Buy
43,600
+27,000
+163% +$83.3K ﹤0.01% 11064
2023
Q4 		$58.6K Buy
16,600
+800
+5% +$2.3K ﹤0.01% 11618
2023
Q3 		$40.9K Sell
15,800
-8,200
-34% -$28.8K ﹤0.01% 11974
2023
Q2 		$94.6K Sell
24,000
-27,800
-54% -$88.2K ﹤0.01% 11022
2023
Q1 		$175K Buy
51,800
+7,000
+16% +$28.5K ﹤0.01% 10397
2022
Q4 		$160K Sell
44,800
-13,600
-23% -$58.1K ﹤0.01% 10502
2022
Q3 		$235K Buy
58,400
+900
+2% +$4.62K ﹤0.01% 10078
2022
Q2 		$256K Buy
57,500
+11,500
+25% +$83K ﹤0.01% 10169
2022
Q1 		$391K Sell
46,000
-25,700
-36% -$181K ﹤0.01% 9959
2021
Q4 		$633K Sell
71,700
-11,800
-14% -$112K ﹤0.01% 9087
2021
Q3 		$868K Buy
83,500
+56,800
+213% +$496K ﹤0.01% 8503
2021
Q2 		$280K Sell
26,700
-24,900
-48% -$246K ﹤0.01% 11426
2021
Q1 		$531K Buy
+51,600
New +$718K ﹤0.01% 9546

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors's SRTA Position: Q1 2026 in Review

Citadel Advisors increased its Strata Critical Medical Inc (SRTA) stake by 46% in Q1 2026, buying an estimated $569K and bringing the position to 372,941 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #6631.

Citadel Advisors first reported a position in SRTA in Q4 2020 and has held it in 21 quarters since. The position peaked at $4.01M in Q4 2024. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Citadel Advisors held 372,941 shares of Strata Critical Medical Inc worth $1.56M as of Q1 2026.
  • Citadel Advisors bought 118,130 Strata Critical Medical Inc shares in Q1 2026, an estimated $569K.
  • Strata Critical Medical Inc made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6631 holding.
  • Citadel Advisors first reported a position in Strata Critical Medical Inc in Q4 2020 and has held it in 21 quarters since.
  • Citadel Advisors's Strata Critical Medical Inc position peaked at $4.01M in Q4 2024.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.